Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Nephrology Nursing Journal Editorial Board Statements of Disclosure: In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.
Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.
Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.
Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.
All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.
This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.
Learning Engagement Activity: For more information about clinical research, refer to the ANNA Online Library for the session entitled, “Understanding Clinical Trials,” presented by Mary Haras, PhD, MBA, APN, NP-C, CNN, and Kristin Larson, MSN, RN, ANP, GNP, CNN, at the ANNA 2017 National Symposium: Click Here! (Additional costs may be associated)
Learning Outcome: After completing this learning activity, the learner will be able to discuss the benefits of a post-discharge telephone follow-up call to adult patients on hemodialysis by experienced nephrology nurses through standardized unit workflow and leveraging of the electronic medical record.
Using Post-Discharge Telephone Follow-Up by Nephrology Nurses to Reduce 30-Day Readmissions and Post-Discharge Complications for Adult Patiets on Hemodialysis
1.40 - CH
0.00 - Rx
You must be logged in and own this product in order to post comments.
10/24/18 1:46 am
This is a process that was started by our clinic over a year ago. However due to the shortage of nurses I do regret that I is not always followed.
2/23/19 3:50 pm
This approach to decreasing readmission's is gaining momentum there is a need for the administration of the LDO's to adopt this process as a norm rather tan an exception. The decrease in health care costs and improvement in patient outcomes can out weigh the cost of hiring personnel.